The goal was always the precise nebulization of disinfection products to reduce germs on all and any surface of a room. As part of the EU biocide notification, the disinfection product was subjected to a large number of tests to demonstrate its effectiveness for all relevant applications. This was not necessary before the new EU Biocide Regulation came into force. Each manufacturer was able to register his biocidal product with BauA without proof of its effectiveness and sell it directly. Effectiveness tests were used to attract customers. This changed with the EU-wide new regulation, although there are still many disinfection products that are not yet approved on the market. The homepage of the Federal Institute for Occupational Safety and Health offers a check, which always shows an updated overview of the biocides that are in the process of approval and thus also proves marketability.
The required evidence of effectiveness for the EU biocide registration by ECHA included standardized suspension tests and surface disinfection tests, such as the 4-field test. The results show that the tested applications are effective. However, the disinfection product should be nebulized, since a suspension test is not sufficiently meaningful. After research, we became aware of the prEN17272 standard, which was specially developed for checking aerogenic disinfection systems.
A system consisting of application technology and the associated disinfectant is always tested.
This was specified in an accredited laboratory, which has the options for testing according to prEN17272. The test was successfully completed with the M-FUN precision nebulizer and the disinfection product FUNA RS05, and the standard-compliant effectiveness for the areas of bactericidal, fungicidal, virucidal (limited virucidal plus) and sporizidic was demonstrated. The raX system for aerogenic disinfection was identified, born and tested!
The M-FUN is part of the raX product!